Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0NBKUP
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
PA289 ADC
|
|||||
| Synonyms |
PA289 ADC
Click to Show/Hide
|
|||||
| Organization |
Iksuda Therapeutics Ltd.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
4
|
|||||
| Antibody Name |
undisclosed
|
Antigen Name |
Undisclosed
|
|||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Site-specific conjugation via PermaLink (PL) technologies.
|
|||||
| Combination Type |
PA289
|
|||||